Fundraising FoxAlgiax
Erkrath, DE · 2 known investors
Find your way into Algiax
Sign up to see every warm intro you have to Algiax
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Algiax team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.
Founders & leadership
DG
Dr. Guido KoopmansChief Scientific Officer
DB
Dr. Birgit HasseHead of CMS and Regulator Affairs
Investors · 2
KfWreportedFrankfurt am Main
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Algiax do?
- Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.
- Who are Algiax's investors?
- Algiax's investors include OCCIDENT, KfW.
- Where is Algiax headquartered?
- Algiax is headquartered in Erkrath, DE.